Erythropoietin resistance as surrogate marker of graft and patient survival in renal transplantation: 3-year prospective multicenter study

Transplantation Proceedings

Volumn 42, Issue 8, 2010, Pages 2935-2937

  Gomez Alamillo, C ^a   Fernandez Fresnedo, G ^a   Ortega, F ^b   Campistol, J M ^c   Gentil, M A ^d   Arias, M ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; ERYTHROPOIETIN; HEMOGLOBIN; IRON; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; STEROID;

ADULT; AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; DIABETES MELLITUS; DOSE CALCULATION; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; VASCULAR DISEASE;

DRUG RESISTANCE; ERYTHROPOIETIN; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 77958531730     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.07.043     Document Type: Article

References (15)

1. Y. Vanrenterghem, C. Ponticelli, and J.M. Morales Prevalence and management of anemia in kidney transplant recipients: a European survey Am J Transplant 3 2003 835
2. G. Fernandez Fresnedo, R. Palomar, and E. Rodrigo Prevalence of anemia in renal transplant patients: results from MOST, an observational trial Transplant Proc 37 2005 3821
3. C. Rigatto, P. Parfrey, and R. Foley Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease J Am Soc Nephrol 13 2002 1084
4. T.C.H. Mix, W. Kazmi, and S. Kham Anemia: a continuing problem following kidney transplantation Am J Transplant 3 2003 1426
5. M. Campise, A. Mikhail, and T. Quaschning Impact of pre-transplant anaemia correction and erythropoietin resistance on long-term graft survival Nephrol Dial Transplant 20 suppl 8 2005 viii8
6. D.W. Johnson, C.A. Pollock, and I.C. Macdougall Erythropoiesis- stimulating agent hyporesponsiveness Nephrology 12 2007 321
7. B. Afzali, S. Al-Khoury, and N. Shah Anemia after renal transplantation Am J Kidney Dis 48 2006 519
8. G.R. Bailie Erythropoietin Effectiveness Index: a quantitative definition of resistance in haemodialysis patients with adequate iron stores Clin Drug Invest 15 1998 57
9. J.M. López-Gómez, I. Pérez-Flores, and R. Jofr Presence of a failed kidney transplant in patients who are on hemodialysis is associated with chronic inflammatory state and EPO resistance J Am Soc Nephrol 15 2004 2494
10. G.A. Kaysen, H.G. Mller, and J. Ding Challenging the validity of the EPO index Am J Kidney Dis 47 2006 166
11. C.A. Solid, R.N. Foley, and J.S. Gill Epoetin use and Kidney Disease Outcomes Quality Initiative hemoglobin targets in patients returning to dialysis with failed renal transplants Kidney Int 71 2007 425
12. M.Z. Molnar, M. Cziraa, and C. Ambrus Anemia is associated with mortality in kidney-transplanted patients: a prospective cohort study Am J Transplant 7 2007 818
13. S.J. Chadban, L. Baines, and K. Polkinghorne Anemia after kidney transplantation is not completely explained by reduced kidney function Am J Kidney Dis 49 2007 301
14. J. Augustine, V. Rodriguez, and A. Padiyar Reduction in erythropoietin resistance after conversion from sirolimus to enteric coated mycophenolate sodium Transplantation 86 2008 548
15. A.T. Kausz, C. Solid, and B.J. Pereira Intractable anemia among hemodialysis patients: a sign of suboptimal management or a marker of disease? Am J Kidney Dis 45 2005 136